IRCT201407151556N62已完成3 期
Saffron in the treatment of mild to moderate OCDL a randomised , double blind and controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •1-Age between 18-60 years old; 2-Diagnosis of OCD based on DSM V; 3- Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale. Exclusion criteria:1- Substance dependence; 2- IQ <70; 3-Any other mental disorder on axis I; 4-Any serious cardiac, renal or hepatic diseases; 5- Receiving psychotropic medications during the last 6 weeks; 6- Pregnancy or breast feeding.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Saffron and AlzheimerIRCT138711051556N1Tehran University of Medical Sciences50
已完成
不适用
Efficacy of saffron as an adjunct treatment for unremitted depression in adultsDepressionACTRN12618000748213Murdoch University160
已完成
3 期
The Efficacy of Supplemental Saffron in Patients with Age-Related Macular DegeneratioAge-related macular degeneration.Degeneration of macula and posterior poleIRCT201205219820N1Eye Research center80
招募中
2 期
The effect of Sulforaphane on the treatment of mild to moderate depression in post percutaneous coronary intervention patientsDepression.Major depressive disorder, single episode, moderateF32.1IRCT20090117001556N128Tehran University of Medical Sciences50
招募中
不适用
The effect of Saffron supplement on active rheumatoid arthritisActive rheumathoid arthritis.Other specified rheumatoid arthritisIRCT201707139472N14Vice-chancellor for research, Iran University of Medical Science66